Literature DB >> 17145736

Helicobacter bilis triggers persistent immune reactivity to antigens derived from the commensal bacteria in gnotobiotic C3H/HeN mice.

Albert E Jergens1, Jennifer H Wilson-Welder, Andrea Dorn, Abigail Henderson, Zhiping Liu, Richard B Evans, Jesse Hostetter, Michael J Wannemuehler.   

Abstract

BACKGROUND: Infection with Helicobacter species has been associated with the development of mucosal inflammation and inflammatory bowel disease (IBD) in several mouse models. However, consensus regarding the role of Helicobacter as a model organism to study microbial-induced IBD is confounded by the presence of a complex colonic microbiota. AIM: To investigate the kinetics and inflammatory effects of immune system activation to commensal bacteria following H bilis colonisation in gnotobiotic mice.
METHODS: C3H/HeN mice harbouring an altered Schaedler flora (ASF) were selectively colonised with H bilis and host responses were investigated over a 10-week period. Control mice were colonised only with the defined flora (DF). Tissues were analysed for gross/histopathological lesions, and bacterial antigen-specific antibody and T-cell responses.
RESULTS: Gnotobiotic mice colonised with H bilis developed mild macroscopic and microscopic lesions of typhlocolitis beginning 3 weeks postinfection. ASF-specific IgG responses were demonstrable within 3 weeks, persisted throughout the 10-week study, and presented as a mixed IgG1:IgG2a profile. Lymphocytes recovered from the mesenteric lymph node of H bilis-colonised mice produced increased levels of interferon gamma, tumour necrosis factor alpha (TNFalpha), interleukin 6 (IL6) and IL12 in response to stimulation with commensal- or H bilis-specific bacterial lysates. In contrast, DF mice not colonised with H bilis did not develop immune responses to their resident flora and remained disease free.
CONCLUSIONS: Colonisation of gnotobiotic C3H/HeN mice with H bilis perturbs the host's response to its resident flora and induces progressive immune reactivity to commensal bacteria that contributes to the development of immune-mediated intestinal inflammation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17145736      PMCID: PMC1994361          DOI: 10.1136/gut.2006.099242

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  41 in total

1.  Reciprocal regulation of polarized cytokine production by effector B and T cells.

Authors:  D P Harris; L Haynes; P C Sayles; D K Duso; S M Eaton; N M Lepak; L L Johnson; S L Swain; F E Lund
Journal:  Nat Immunol       Date:  2000-12       Impact factor: 25.606

2.  Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in Tg(epsilon26) mice.

Authors:  C Veltkamp; S L Tonkonogy; Y P De Jong; C Albright; W B Grenther; E Balish; C Terhorst; R B Sartor
Journal:  Gastroenterology       Date:  2001-03       Impact factor: 22.682

3.  Helicobacter hepaticus infection triggers inflammatory bowel disease in T cell receptor alphabeta mutant mice.

Authors:  E Y Chin; C A Dangler; J G Fox; D B Schauer
Journal:  Comp Med       Date:  2000-12       Impact factor: 0.982

4.  Monoassociation of SCID mice with Helicobacter muridarum, but not four other enterics, provokes IBD upon receipt of T cells.

Authors:  Han-Qing Jiang; Natasha Kushnir; M Christine Thurnheer; Nicolaas A Bos; John J Cebra
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

5.  Enteric lesions in SCID mice infected with "Helicobacter typhlonicus," a novel urease-negative Helicobacter species.

Authors:  C L Franklin; L K Riley; R S Livingston; C S Beckwith; R R Hook; C L Besch-Williford; R Hunziker; P L Gorelick
Journal:  Lab Anim Sci       Date:  1999-10

6.  Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice.

Authors:  A Burich; R Hershberg; K Waggie; W Zeng; T Brabb; G Westrich; J L Viney; L Maggio-Price
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-09       Impact factor: 4.052

7.  Cytolethal distending toxin in avian and human isolates of Helicobacter pullorum.

Authors:  V B Young; C C Chien; K A Knox; N S Taylor; D B Schauer; J G Fox
Journal:  J Infect Dis       Date:  2000-07-19       Impact factor: 5.226

8.  Helicobacter hepaticus does not induce or potentiate colitis in interleukin-10-deficient mice.

Authors:  L A Dieleman; A Arends; S L Tonkonogy; M S Goerres; D W Craft; W Grenther; R K Sellon; E Balish; R B Sartor
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

9.  Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice.

Authors:  Lillian Maggio-Price; Donna Shows; Kim Waggie; Andrew Burich; Weiping Zeng; Sabine Escobar; Phil Morrissey; Joanne L Viney
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

10.  Interferon-gamma and interleukin-10 reciprocally regulate endothelial junction integrity and barrier function.

Authors:  T Oshima; F S Laroux; L L Coe; Z Morise; S Kawachi; P Bauer; M B Grisham; R D Specian; P Carter; S Jennings; D N Granger; T Joh; J S Alexander
Journal:  Microvasc Res       Date:  2001-01       Impact factor: 3.514

View more
  55 in total

1.  Ulcerative typhlocolitis associated with Helicobacter mastomyrinus in telomerase-deficient mice.

Authors:  K A Eaton; J S Opp; B M Gray; I L Bergin; V B Young
Journal:  Vet Pathol       Date:  2010-10-06       Impact factor: 2.221

Review 2.  IBD-what role do Proteobacteria play?

Authors:  Indrani Mukhopadhya; Richard Hansen; Emad M El-Omar; Georgina L Hold
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-21       Impact factor: 46.802

Review 3.  The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models.

Authors:  Sandra Nell; Sebastian Suerbaum; Christine Josenhans
Journal:  Nat Rev Microbiol       Date:  2010-07-12       Impact factor: 60.633

4.  The role of H. pylori infection in gall bladder cancer: clinicopathological study.

Authors:  Ehsan Hassan Hassan; Shawkat S Gerges; Kamal A El-Atrebi; Hala T El-Bassyouni
Journal:  Tumour Biol       Date:  2015-04-16

Review 5.  Association between Helicobacter spp. infections and hepatobiliary malignancies: a review.

Authors:  Fany Karina Segura-López; Alfredo Güitrón-Cantú; Javier Torres
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

Review 6.  The human symbiont Mucispirillum schaedleri: causality in health and disease.

Authors:  Simone Herp; Abilash Chakravarthy Durai Raj; Marta Salvado Silva; Simon Woelfel; Bärbel Stecher
Journal:  Med Microbiol Immunol       Date:  2021-05-22       Impact factor: 3.402

Review 7.  Helicobacter bilis: bacterial provocateur orchestrates host immune responses to commensal flora in a model of inflammatory bowel disease.

Authors:  J G Fox
Journal:  Gut       Date:  2007-07       Impact factor: 23.059

8.  Isolation of Helicobacter spp. from mice with rectal prolapses.

Authors:  Cassandra L Miller; Sureshkumar Muthupalani; Zeli Shen; James G Fox
Journal:  Comp Med       Date:  2014-06       Impact factor: 0.982

9.  Quantitative trait loci in a bacterially induced model of inflammatory bowel disease.

Authors:  Andrew E Hillhouse; Matthew H Myles; Jeremy F Taylor; Elizabeth C Bryda; Craig L Franklin
Journal:  Mamm Genome       Date:  2011-06-30       Impact factor: 2.957

10.  Helicobacter bilis Infection Alters Mucosal Bacteria and Modulates Colitis Development in Defined Microbiota Mice.

Authors:  Todd Atherly; Curtis Mosher; Chong Wang; Jesse Hostetter; Alexandra Proctor; Meghan W Brand; Gregory J Phillips; Michael Wannemuehler; Albert E Jergens
Journal:  Inflamm Bowel Dis       Date:  2016-11       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.